Cash Flow Jacobson Pharma Corp. Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
373.00
254.00
251.00
235.00
226.00
262.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-4.00
-13.00
86.00
0.00
0.00
-52.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
543.00
512.00
648.00
409.00
411.00
375.00
Cash Flow from Investing Activities
-314.00
-84.00
-44.00
-52.00
-375.00
-451.00
Cash Flow from Financing Activities
-131.00
-1,053.00
-45.00
-357.00
21.00
-133.00
Net Cash Inflow / Outflow
97.00
-624.00
557.00
-1.00
58.00
-208.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
1.00
0.00
0.00
1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Jacobson Pharma Corp. Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
373.228
241.6
132.00
54.48%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-4.075
-30.637
26.00
86.70%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
543.471
224.938
319.00
141.61%
Cash Flow from Investing Activities
-314.452
-75.823
-239.00
-314.72%
Cash Flow from Financing Activities
-131.296
-84.203
-47.00
-55.93%
Net Cash Inflow / Outflow
97.108
65.041
32.00
49.30%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.615
0.129
0.00
-576.74%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 6.04% vs -20.93% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
543.47
512.53
6.04%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
